Cargando…

THU467 Pharmacokinetics And Pharmacodynamics Of Garetosmab In Patients With Fibrodysplasia Ossificans Progressiva

Disclosure: Y. Wang: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron Pharmaceuticals. J. Nguyen: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron Pharmaceuticals. R.R. de Ruiter: None. J. Mendell: Employee; Self; Regeneron Pharmaceuticals. Stock Owner;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuhuan, Nguyen, Jenny-Hoa, de Ruiter, Ruben R D, Mendell, Jeanne, Srinivasan, Dushyanth, Davis, John D, Eekhoff, Marelise W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Bone And Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554036/ http://dx.doi.org/10.1210/jendso/bvad114.428

Ejemplares similares

OR29-06 Flare-Ups In Patients With Fibrodysplasia Ossificans Progressiva Reduced By Garetosmab Treatment: LUMINA-1 Data
por: Dahir, Kathryn M, et al.
Publicado: (2023)

PSAT180 Fibrodysplasia Ossificans Progressiva (FOP) A Case Series
por: Almonaei, Khulod, et al.
Publicado: (2022)

THU402 New Heterotopic Ossification Lesions In Patients With Fibrodysplasia Ossificans Progressiva Measured By PET/CT vs CT Only
por: Trotter, Dinko Gonzalez, et al.
Publicado: (2023)

Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
por: Di Rocco, Maja, et al.
Publicado: (2023)

SUN-344 Patients with Fibrodysplasia Ossificans Progressiva Have an Increased Prevalence of Cardiac Conduction Abnormalities
por: Kou, Samuel, et al.
Publicado: (2020)

OR29-05 A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP): 12-Month Outcomes
por: Mukaddam, Mona Al, et al.
Publicado: (2020)

Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives
por: Smilde, Bernard J, et al.
Publicado: (2022)

MON-348 Surgical Management of Bilateral Hip Fracture in a Patient with Fibrodysplasia Ossificans Progressiva Treated with Palovarotene
por: Singh, Sukhmani, et al.
Publicado: (2020)

ODP108 Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva: Methodology of the Phase III Open-Label PIVOINE Rollover Trial
por: Artyomenko, Alex, et al.
Publicado: (2022)

ODP103 IPN60130 for the Treatment of Fibrodysplasia Ossificans Progressiva: Methodology of the Randomized, Double-Blind, Placebo-Controlled Phase II FALKON Trial
por: Karimian, Negar, et al.
Publicado: (2022)

Limitations of Jaw Movement in Fibrodysplasia Ossificans Progressiva: A Review
por: Schoenmaker, Ton, et al.
Publicado: (2022)

Fibrodysplasia ossificans progressiva
por: Smit, Chané, et al.
Publicado: (2023)

RF18 | PSAT149 Joint Function and Quality of Life in Fibrodysplasia Ossificans Progressiva: Results from an International Burden of Illness Survey of Patients and Family Members
por: Böing, Elaine A, et al.
Publicado: (2022)

TGF-Beta Induces Activin A Production in Dermal Fibroblasts Derived from Patients with Fibrodysplasia Ossificans Progressiva
por: de Ruiter, Ruben D., et al.
Publicado: (2023)

Radiotherapy in Fibrodysplasia Ossificans Progressiva: A Case Report and Systematic Review of the Literature
por: Botman, Esmée, et al.
Publicado: (2020)

Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles
por: Eekhoff, Elisabeth M.W., et al.
Publicado: (2022)

Recent Topics in Fibrodysplasia Ossificans Progressiva
por: Katagiri, Takenobu, et al.
Publicado: (2018)

Diagnostic Value of Magnetic Resonance Imaging in Fibrodysplasia Ossificans Progressiva
por: Botman, Esmée, et al.
Publicado: (2020)

Deterioration of pulmonary function: An early complication in Fibrodysplasia Ossificans Progressiva
por: Botman, Esmée, et al.
Publicado: (2021)

Induced Pluripotent Stem Cells to Model Human Fibrodysplasia Ossificans Progressiva
por: Cai, Jie, et al.
Publicado: (2015)

Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects
por: Pignolo, Robert J, et al.
Publicado: (2011)

Quality of life of patients with fibrodysplasia ossificans progressiva
por: Ortiz-Agapito, Fernando, et al.
Publicado: (2015)

Bone Resection Osteotomy in Fibrodysplasia Ossificans Progressiva
por: Colmenares-Bonilla, Douglas, et al.
Publicado: (2018)

Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva
por: Khan, Fatima, et al.
Publicado: (2021)

Fibrodysplasia Ossificans Progressiva: A Challenging Diagnosis
por: De Brasi, Daniele, et al.
Publicado: (2021)

Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)
por: Hsiao, Edward C., et al.
Publicado: (2018)

The effect of Activin‐A on periodontal ligament fibroblasts‐mediated osteoclast formation in healthy donors and in patients with fibrodysplasia ossificans progressiva
por: Schoenmaker, Ton, et al.
Publicado: (2018)

Activin-A Induces Fewer, but Larger Osteoclasts From Monocytes in Both Healthy Controls and Fibrodysplasia Ossificans Progressiva Patients
por: Schoenmaker, Ton, et al.
Publicado: (2020)

Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva Osteoclasts
por: Schoenmaker, Ton, et al.
Publicado: (2023)

Activin-A Induces Early Differential Gene Expression Exclusively in Periodontal Ligament Fibroblasts from Fibrodysplasia Ossificans Progressiva Patients
por: Schoenmaker, Ton, et al.
Publicado: (2021)

Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis
por: Kaplan, Frederick S., et al.
Publicado: (2012)

The Diversity of the Clinical Phenotypes in Patients With Fibrodysplasia Ossificans Progressiva
por: Al Kaissi, Ali, et al.
Publicado: (2016)

Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
por: Ventura, Francesc, et al.
Publicado: (2021)

The Developmental Phenotype of the Great Toe in Fibrodysplasia Ossificans Progressiva
por: Towler, O. Will, et al.
Publicado: (2020)

Fibrodysplasia Ossificans Progressiva: A Report of Four Cases
por: Elamin, Mohamed, et al.
Publicado: (2022)

Crohn's Disease in a Patient With Fibrodysplasia Ossificans Progressiva
por: Havlichek, Daniel, et al.
Publicado: (2022)

Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva
por: Williams, Eleanor, et al.
Publicado: (2021)

Recent progress in drug development for fibrodysplasia ossificans progressiva
por: Meng, Xinmiao, et al.
Publicado: (2022)

Microarchitecture of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva: An HR-pQCT Case Series
por: Botman, Esmée, et al.
Publicado: (2021)

ACVR1 mutation and Fibrodysplasia Ossificans Progressiva in Chinese children
por: Ho, Assunta CH, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0ejjfj40enk3kqu1jaie94mtkd